Nusinersen and risdiplam for treating spinal muscular atrophy (review of TA588 and TA755) [ID6195]
In development
Reference number: GID-TA11386
Expected publication date: TBC
There has been an update to the timelines for this appraisal following a request from the EAG for additional time to complete their report. As a result, the consultation on the EAG report will now take place between 21 July and 10 September, with the first committee meeting taking place on 11 November 2025.